In a mouse tumor model, intratumoral treatment with pH modulating injectable gel (pHe-MIG) generates immune-favorable TME, as evidenced by the decrease of immune-suppressive cells and increase of tumor infiltrating CD8+ T cells (Jin et al., 2019). This evidence concerns the gene CD8A and neoplasm.